Risk factors for SARS-CoV-2 infections and outbreaks in care home staff and residents

Grant number: 222907/Z/21/Z

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2023
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Maria Krutikov
  • Research Location

    United Kingdom
  • Lead Research Institution

    University College London
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

In 2020, over one in four people who died from COVID-19 infection in England lived in a care-home . Reducing deaths in this vulnerable group by protecting them from infection using approaches like vaccination, is a priority. To understand if these work, and who has the biggest risk of getting infected, we need to know how many people have had the infection and how this affects their immune system. However, we cannot do this yet as collecting this information is difficult. To answer these questions, researchers from UCL have set up the VIVALDI study, one of the biggest studies of COVID-19 in care-homes. Care-home staff and residents who take part have repeated swab testing to find out who is infected, and blood testing to see who had COVID-19 before. Information is collected about hospital admissions and deaths in these people, and about the care-homes themselves, like size. Using this information, I will find out which care-homes have had the most infections, who is most likely to get infected, and in people who have been infected or vaccinated, how long they are protected for. The results will help government officials understand which changes can prevent COVID-19 and other infections in care-homes.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

VIVALDI-CT shaping care home COVID-19 testing policy: A pragmatic cluster randomised controlled trial of asymptomatic testing compared to standard care in care home staff.

Protocol for VIVALDI social care: Pilot study to reduce infections, outbreaks and antimicrobial resistance in care homes for older adults.

Protocol for VIVALDI social care: Pilot study to reduce infections, outbreaks and antimicrobial resistance in care homes for older adults

Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study.

Built Environment and SARS-CoV-2 Transmission in Long-Term Care Facilities: Cross-Sectional Survey and Data Linkage.

Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results.

COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023.

Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study

Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI).